Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,509 | 246 | 97.5% |
| Education | $114.84 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $983.72 | 50 | $0 (2024) |
| Alkermes, Inc. | $681.17 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $563.39 | 36 | $0 (2024) |
| Indivior Inc. | $360.70 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $336.36 | 18 | $0 (2024) |
| ABBVIE INC. | $293.22 | 16 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $239.65 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $228.48 | 15 | $0 (2024) |
| Axsome Therapeutics, Inc. | $217.29 | 9 | $0 (2024) |
| Lundbeck LLC | $175.12 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $697.95 | 30 | Teva Pharmaceuticals USA, Inc. ($85.02) |
| 2023 | $1,757 | 102 | Alkermes, Inc. ($254.17) |
| 2022 | $1,180 | 58 | Janssen Pharmaceuticals, Inc ($267.82) |
| 2021 | $206.63 | 10 | Janssen Pharmaceuticals, Inc ($73.56) |
| 2020 | $94.86 | 5 | Janssen Pharmaceuticals, Inc ($94.86) |
| 2019 | $169.92 | 10 | Janssen Pharmaceuticals, Inc ($124.86) |
| 2018 | $208.28 | 12 | Janssen Pharmaceuticals, Inc ($85.77) |
| 2017 | $308.67 | 21 | Janssen Pharmaceuticals, Inc ($104.29) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $36.77 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: CNS | ||||||
| 11/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Neurology | ||||||
| 11/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $31.03 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Neurology | ||||||
| 07/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Central Nervous System | ||||||
| 07/12/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.88 | General |
| 07/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Neuroscience | ||||||
| 06/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: Neuropsychiatry | ||||||
| 05/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Neuroscience | ||||||
| 04/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CNS | ||||||
| 03/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ADHD | ||||||
| 03/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Neurology | ||||||
| 03/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: PSYCHIATRY | ||||||
| 02/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $22.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 462 | 1,414 | $251,354 | $86,244 |
| 2022 | 8 | 412 | 1,096 | $233,641 | $82,763 |
| 2021 | 5 | 489 | 1,119 | $211,122 | $68,316 |
| 2020 | 7 | 825 | 1,799 | $283,871 | $97,913 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 412 | $72,040 | $30,847 | 42.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 479 | $106,725 | $29,473 | 27.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 52 | 61 | $17,035 | $8,069 | 47.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 54 | $12,320 | $5,163 | 41.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 49 | 66 | $20,241 | $4,164 | 20.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 27 | 27 | $8,715 | $3,095 | 35.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 26 | $8,064 | $2,430 | 30.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 52 | $3,630 | $2,124 | 58.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 52 | 221 | $2,193 | $697.19 | 31.8% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 12 | 16 | $390.00 | $181.10 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 297 | $58,212 | $25,804 | 44.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 353 | $75,300 | $18,811 | 25.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 92 | 96 | $26,338 | $12,654 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 53 | $14,575 | $7,054 | 48.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 44 | 44 | $11,704 | $5,860 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 64 | $19,050 | $5,047 | 26.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 56 | 71 | $20,936 | $3,913 | 18.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 33 | 64 | $7,040 | $3,435 | 48.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 11 | 54 | $486.00 | $186.51 | 38.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 195 | 213 | $54,678 | $26,325 | 48.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 107 | 341 | $70,587 | $19,056 | 27.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 82 | 408 | $49,769 | $11,719 | 23.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 83 | 112 | $26,498 | $6,182 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 34 | $6,664 | $3,272 | 49.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $2,926 | $1,761 | 60.2% |
About Dr. Adam Nicholas, MD
Dr. Adam Nicholas, MD is a Psychiatry healthcare provider based in Auburn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033309950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Nicholas, MD has received a total of $4,623 in payments from pharmaceutical and medical device companies, with $697.95 received in 2024. These payments were reported across 248 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,509).
As a Medicare-enrolled provider, Nicholas has provided services to 2,188 Medicare beneficiaries, totaling 5,428 services with total Medicare billing of $335,235. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Auburn, MI
- Active Since 07/26/2007
- Last Updated 09/11/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033309950
Products in Payments
- SPRAVATO (Drug) $542.43
- ARISTADA (Drug) $455.04
- INVEGA SUSTENNA (Drug) $441.29
- PERSERIS (Drug) $317.50
- VRAYLAR (Drug) $293.22
- INGREZZA (Drug) $239.65
- TRINTELLIX (Drug) $228.48
- Auvelity (Drug) $217.29
- REXULTI (Drug) $216.72
- Austedo XR (Drug) $198.58
- ABILIFY MAINTENA (Drug) $191.53
- AUSTEDO (Drug) $156.34
- CAPLYTA (Drug) $124.87
- Aristada 441 mg (Drug) $111.92
- BRINTELLIX (Drug) $103.23
- UZEDY (Drug) $82.43
- LATUDA (Drug) $68.34
- Vivitrol (Drug) $61.93
- QUVIVIQ (Drug) $60.35
- Azstarys (Drug) $52.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Auburn
Daniel Binus, Md, MD
Psychiatry — Payments: $7,756
Aaron Hawkins, M.d, M.D
Psychiatry — Payments: $4,109
Abbas Ispahani, Md, MD
Psychiatry — Payments: $2,922
Dr. Blair Romer, M.d, M.D
Psychiatry — Payments: $679.18
Gene Gomez, Md, MD
Psychiatry — Payments: $501.65
Jennifer Smith, Md, MD
Psychiatry — Payments: $386.97